The University of Sassari is a university located in Sassari, Italy. It was founded in 1562 and is organized in 13 departments. The University of Sassari earned first place in the rankings for the best “medium- sized” Italian university, in 2009–2010, by the Censis Research Institute.

During the past decade, Università di Sassari conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Università di Sassari" #1 sponsor was "Celgene" with 1 trials, followed by "Fondazione EMN Italy Onlus" with 1 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 1 trials sponsored, "National Cancer Institute, Naples" with 1 trials sponsored and "Nobel Biocare" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Università di Sassari" #1 collaborator was "Charite University, Berlin, Germany" with 1 trials as a collaborator and "University of Campania "Luigi Vanvitelli"" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Università di Sassari" are "Breast Cancer" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Edentulous" (1 trials), "Multiple Myeloma" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Università di Sassari" in a lesser frequency.

Most popular intervention types in "Università di Sassari" are "Drug" (4 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Azacitidine" (1 trials), "Carfilzomib" (1 trials), "Cyclophosphamide" (1 trials), "Dexamethasone" (1 trials) and "Doxorubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Università di Sassari" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Università di Sassari". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Università di Sassari, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Università di Sassari, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Università di Sassari has several departments that took part in Clinical trials: "Department of Surgery, Microsurgery and Medicine Sciences University of Sassari" - 5 trials, "Complex Operative Unit of Dentistry" - 3 trials, "Department of Biomedical Sciences- University of Sassari" - 2 trials